0591-0860
Generic: lisinopril and hydrochlorothiazide
Labeler: actavis pharma, inc.Drug Facts
Product Profile
Brand Name
Generic Name
lisinopril and hydrochlorothiazide
Labeler
actavis pharma, inc.
Dosage Form
TABLET
Active Ingredients
hydrochlorothiazide 12.5 mg/1, lisinopril 10 mg/1
Identifiers & Regulatory
Product NDC
0591-0860
Product ID
0591-0860_6ec7d3cd-452d-42e0-ac10-8730bb3f0ba6
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Listing Expiration
2026-12-31
Marketing Start
2003-03-01
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05910860
Hyphenated Format
0591-0860
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisinopril and hydrochlorothiazide (source: label)
Generic Name
lisinopril and hydrochlorothiazide (source: ndc)
Application Number
ANDA076194 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 12.5 mg/1
- 10 mg/1
Packaging
- 50000 TABLET in 1 BAG (0591-0860-00)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "6ec7d3cd-452d-42e0-ac10-8730bb3f0ba6", "openfda": {}, "finished": false, "packaging": [{"description": "50000 TABLET in 1 BAG (0591-0860-00)", "package_ndc": "0591-0860-00", "marketing_start_date": "01-MAR-03"}], "product_id": "0591-0860_6ec7d3cd-452d-42e0-ac10-8730bb3f0ba6", "dosage_form": "TABLET", "product_ndc": "0591-0860", "generic_name": "Lisinopril and hydrochlorothiazide", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "LISINOPRIL", "strength": "10 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20030301", "listing_expiration_date": "20261231"}